ArticleThe New England journal of medicine2018
Durvalumab in Stage III Non-Small-Cell Lung Cancer.
Matteo Santoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe New England journal of medicine2018
Matteo Santoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.